Abivax SA - American Depositary Shares (ABVX)

The financial markets are abuzz with significant corporate developments as several key companies navigate pivotal moments, ranging from prestigious S&P index inclusions to critical quarterly earnings reports. Robinhood Markets (NASDAQ: HOOD) and AppLovin (NASDAQ: APP) are making headlines with their impending entry into the benchmark S&P 500 index,

This little-known biotech might still deliver strong returns.

The results represent a best-case scenario for the company in treating inflammatory bowel disease, according to one analyst.

Abivax shares jump as obefazimod meets key Phase 3 trial endpoints in ulcerative colitis with strong remission rates and a favorable safety profile.

Shares of Vicor Corporation (NASDAQ:VICR) rose sharply in pre-market trading after posting second-quarter results.

The drug candidate demonstrated a placebo-adjusted remission rate of 19.3% in the first study and 13.4% in the second study.

The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Companies Reporting Before The Bell • Ocugen (NASDAQ:OCGN) is estimated to report earnings for its fourth quarter.

Shares of cross-border logistics provider Globavend opened for trading on Wednesday. A clinical-stage biotechnology company and an insurance company also opened up to close out another quiet week for IPOs in the US.

Shares of e-commerce retailer Webuy soared in their trading debut after the IPO was priced at the low end of the $4.00-$4.50 per share range. The company said it expects to use the proceeds for marketing, development, and expansion of business.